Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
19.89
-0.79 (-3.82%)
Nov 17, 2026, 3:00 PM CST

Nanjing Vazyme Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,2837,9638,81112,80821,25742,401
Market Cap Growth
8.54%-9.63%-31.21%-39.74%-49.87%-
Enterprise Value
8,3656,1006,99510,67018,87741,383
Last Close Price
20.6814.9916.4923.6637.7975.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13111.40---35.7762.51
Forward PE
143.0074.6143.6848.0323.2157.10
PS Ratio
6.805.786.409.965.9622.69
PB Ratio
2.922.102.233.184.6110.27
P/TBV Ratio
3.102.232.373.374.8010.32
P/FCF Ratio
43.6942.86---119.49
P/OCF Ratio
38.8834.15-83.7228.9168.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.564.435.088.305.2922.15
EV/EBITDA Ratio
145.17---20.6654.37
EV/EBIT Ratio
----22.2056.70
EV/FCF Ratio
35.7732.84---116.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.220.190.320.100.02
Debt / EBITDA Ratio
14.3636.6118.95-0.470.12
Debt / FCF Ratio
3.544.54---0.26
Net Debt / Equity Ratio
-0.53-0.53-0.48-0.54-0.61-0.81
Net Debt / EBITDA Ratio
-114.47101.87656.2812.62-3.07-4.42
Net Debt / FCF Ratio
-7.99-10.8322.5227.4512.32-9.48
Asset Turnover
0.310.270.260.220.670.60
Inventory Turnover
1.441.301.241.454.592.08
Quick Ratio
3.033.193.502.533.569.76
Current Ratio
3.363.563.952.783.9610.46
Return on Equity (ROE)
-0.26%-0.58%-0.49%-1.69%13.58%24.85%
Return on Assets (ROA)
-0.78%-1.39%-1.31%-2.89%10.02%14.67%
Return on Invested Capital (ROIC)
-3.55%-5.85%-5.83%-14.91%64.41%119.81%
Return on Capital Employed (ROCE)
-1.60%-2.80%-2.70%-6.40%17.50%17.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.01%-0.21%-0.21%-0.55%2.80%1.60%
FCF Yield
2.29%2.33%-0.96%-0.62%-1.07%0.84%
Dividend Yield
1.93%2.50%0.81%0.31%2.35%0.37%
Payout Ratio
21470.40%---22.25%0.66%
Buyback Yield / Dilution
-79.68%-14.77%8.27%1.18%-9.95%-1.96%
Total Shareholder Return
-77.80%-12.28%9.08%1.49%-7.60%-1.59%